Clinical Trial Update: Golimumab Plus UVB-311nm in Psoriasis [NA]

View source ↗

Summary

A clinical trial evaluating golimumab plus UVB-311 nm phototherapy for psoriasis has been terminated. The study was sponsored by the Medical University of Graz.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Medical University of Graz | Conditions: Psoriasis | NA | Status: TERMINATED